Intake of another drug during study period [Outliers]

posted by Helmut Homepage – Vienna, Austria, 2006-09-21 14:50 (6806 d 17:18 ago) – Posting: # 253
Views: 6,915

Dear velupharm,

I agree with Chintan's answer.
Don't forget to refer it together with your justification of keeping the subject in the study (lacking interaction) in sections 10.2 & 16.2.2 of the clinical study report.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
133 visitors (0 registered, 133 guests [including 6 identified bots]).
Forum time: 08:09 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5